OneVentures
Team Portfolio Funds Entrepreneurs Blog News Investors
TeamPortfolioFundsEntrepreneursBlogNewsInvestors
OneVentures

Hatchtech announce successful End-of-Phase 2 for head lice product DeOvo™

 
Learn More
 
Media ReleaseCarolyn MillerSeptember 4, 2012Hatchtech, Paul Kelly
Twitter LinkedIn0 0 Likes
Previous

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Media ReleaseCarolyn MillerOctober 9, 2012Paul Kelly, Vaxxas
Next

Virtual patient gets funding injection

Sydney Morning HeraldCarolyn MillerAugust 9, 2012Smart Sparrow, Michelle Deaker

Suite 13.02, 179 Elizabeth Street, Sydney NSW 2000

enquiries@one-ventures.com

+61 2 8205 7379

Disclaimer

Responsible Investment Policy

Privacy Policy

 
 
OneVentures Pty Ltd
179 Elizabeth Street (Suite 13.02),
Sydney, NSW, 2000,
Australia
+61 2 8205 7379 enquiries@one-ventures.com
Hours

Copyright © 2017 OneVentures Pty Ltd